Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Brian Garibaldi and Yanxun Xu.
Brian Garibaldi
Connection Strength
1.455
Yanxun Xu
  1. Comparison of Time to Clinical Improvement With vs Without Remdesivir Treatment in Hospitalized Patients With COVID-19. JAMA Netw Open. 2021 03 01; 4(3):e213071.
    View in: PubMed
    Score: 0.932
  2. Peripheral Plasma Cells Associated with Mortality Benefit in Severe COVID-19: A Marker of Disease Resolution. Am J Med. 2021 08; 134(8):1029-1033.
    View in: PubMed
    Score: 0.234
  3. Tocilizumab for the Treatment of COVID-19 Among Hospitalized Patients: A Matched Retrospective Cohort Analysis. Open Forum Infect Dis. 2021 Jan; 8(1):ofaa598.
    View in: PubMed
    Score: 0.230
  4. Development of Severe COVID-19 Adaptive Risk Predictor (SCARP), a Calculator to Predict Severe Disease or Death in Hospitalized Patients With COVID-19. Ann Intern Med. 2021 06; 174(6):777-785.
    View in: PubMed
    Score: 0.058
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.